FDA OPDP Sends Untitled Letter to Merz Over Social Media Post Thomas Sullivan Dec 11, 2024 0 The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an Untitled Letter…
DTC Updates from FDA’s Office of Prescription Drug Promotion: Standards… Thomas Sullivan Nov 15, 2024 0 In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the…
Anti Kickback Policy and Medicine Compliance Update May 2023 Issue Features: Regulatory… Thomas Sullivan May 13, 2023 0 Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
